Issue Date | Title | Author(s) |
2019-01-01 | Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain | McCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S |
2016-08-11 | The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial. | Bush, SH; Lacaze-Masmonteil, N; McNamara-Kilian, MT; MacDonald, AR; Tierney, S; Momoli, F; Agar, M; Currow, DC; Lawlor, PG |
2023-09 | Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study. | Agar, MR; Nowak, AK; Hovey, EJ; Barnes, EH; Simes, J; Vardy, JL; Wheeler, HR; Kong, BY; Leonard, R; Hall, M; Tim, E; Spyridopoulos, D; Sim, H-W; Lwin, Z; Dowling, A; Harrup, R; Jennens, R; Kichenadasse, G; Dunlop, T; Gzell, C; Koh, E-S |
2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
2019-09-12 | Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. | Hardy, JR; Skerman, H; Philip, J; Good, P; Currow, DC; Mitchell, G; Yates, P |
2023-03 | Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study. | Ferreira, DH; Ekström, M; Fazekas, B; Currow, DC |
2017 | Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care A Randomized Clinical Trial | Agar, M; Lawlor, P; Quinn, S; Draper, B; Caplan, G; Rowett, D; Sanderson, C; Hardy, J; Le, B; Eckermann, S; McCaffrey, N; Devilee, L; Fazekas, B; Hill, M; Currow, D |
2023-10-12 | Participant Safety in Multisite, Randomized, Double-Blind, Placebo-Controlled Clinical Trials in Hospice/Palliative Care: Data from the Contracted Studies of the Australian National Palliative Care Clinical Studies Collaborative. | Currow, DC; Fazekas, B; Brown, L; Kochovska, S; Clark, K; Agar, MR |
2023-09 | Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial. | Ferreira, DH; Ekström, M; Bajwah, S; Fazekas, B; Currow, DC |
2024-05-01 | Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |